0001438133-21-000108.txt : 20210729 0001438133-21-000108.hdr.sgml : 20210729 20210729174905 ACCESSION NUMBER: 0001438133-21-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210727 FILED AS OF DATE: 20210729 DATE AS OF CHANGE: 20210729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leal James CENTRAL INDEX KEY: 0001866570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 211128928 MAIL ADDRESS: STREET 1: C/O TANDEM DIABETES CARE, INC. STREET 2: 11075 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_162759527141267.xml FORM 4 X0306 4 2021-07-27 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001866570 Leal James C/O TANDEM DIABETES CARE, INC. 11075 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 SVP, Operations Common Stock 2021-07-27 4 M 0 1666 51.50 A 5262 D Common Stock 2021-07-27 4 S 0 1666 102.2504 D 3596 D Stock Option 51.5 2021-07-27 4 M 0 1666 51.50 D Common Stock 1666.0 31667 D Represents shares of common stock received upon exercise of a stock option award. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $102.17 to $102.26. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The options vested as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). The expiration date for these options is 10 years from the date of grant. s/ David B. Berger, Attorney-in-Fact for James A. Leal 2021-07-29